Literature DB >> 15828941

Opioids heal ischemic wounds in the rat.

Tasneem Poonawala1, Brett K Levay-Young, Robert P Hebbel, Kalpna Gupta.   

Abstract

Opioids are sometimes used to treat pain in ulcerative wounds, and it is speculated that pain interferes with the healing process. Because the direct effect of opioids on this process remains unknown, we examined the effect of topically applied opioids on the healing of open ischemic wounds in rats. Topically applied opioids hastened wound closure, particularly in the first 4 days when no healing was initiated in phosphate buffered saline solution-treated wounds. After 1 week of application, fentanyl, hydromorphone, and morphine resulted in 66%, 55%, and 42% wound closure, respectively, as compared to only 15% in control wounds. Opioid-induced healing was accompanied by a 1.5- to 2.5-fold increase in nuclear density in the granulation tissue and 45-87% increase in angiogenesis as compared to phosphate buffered saline solution-treated wounds. Fentanyl showed significantly improved healing compared to morphine and hydromorphone (p < 0.05, fentanyl vs. others). Fentanyl-induced healing was inhibited by the opioid receptor antagonist naloxone, suggesting that peripheral opioid receptor(s) mediate the healing process. Opioids accelerate healing by up-regulating both endothelial and inducible nitric oxide synthase and the vascular endothelial-derived growth factor receptor Flk1 in the wounds. We envision that opioids can be used topically to accelerate wound healing in diverse clinical conditions ranging from surgical incisions to nonhealing ischemic ulcers in pathophysiological conditions and in hospice patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828941     DOI: 10.1111/j.1067-1927.2005.130207.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  33 in total

Review 1.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

2.  Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore.

Authors:  Gianfranco Balboni; Severo Salvadori; Claudio Trapella; Brian I Knapp; Jean M Bidlack; Lawrence H Lazarus; Xuemei Peng; John L Neumeyer
Journal:  ACS Chem Neurosci       Date:  2010-02-17       Impact factor: 4.418

Review 3.  Angiogenesis: a curse or cure?

Authors:  K Gupta; J Zhang
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

Review 4.  Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.

Authors:  David Brinkman; Jiang H Wang; Henry P Redmond
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000

5.  Non-thermal plasma suppresses bacterial colonization on skin wound and promotes wound healing in mice.

Authors:  Ying Yu; Ming Tan; Hongxiang Chen; Zhihong Wu; Li Xu; Juan Li; Jingjiang Cao; Yinsheng Yang; Xuemin Xiao; Xin Lian; Xinpei Lu; Yating Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

6.  Morphine promotes neovascularizing retinopathy in sickle transgeneic mice.

Authors:  Kalpna Gupta; Chunsheng Chen; Gerard A Lutty; Robert P Hebbel
Journal:  Blood Adv       Date:  2019-04-09

7.  Topical fentanyl stimulates healing of ischemic wounds in diabetic rats.

Authors:  Mihir Gupta; Tasneem Poonawala; Mariya Farooqui; Marna E Ericson; Kalpna Gupta
Journal:  J Diabetes       Date:  2015-01-15       Impact factor: 4.006

8.  Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification.

Authors:  Lixin Kan; Amelia A Mutso; Tammy L McGuire; Apkar Vania Apkarian; John A Kessler
Journal:  Inflamm Res       Date:  2013-12-11       Impact factor: 4.575

9.  Opiates and the development of post-injury complications: a review.

Authors:  Martin G Schwacha
Journal:  Int J Clin Exp Med       Date:  2008-01-20

10.  Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.

Authors:  Alysia N Lozano-Ondoua; Katherine E Hanlon; Ashley M Symons-Liguori; Tally M Largent-Milnes; Josh J Havelin; Henry L Ferland; Anupama Chandramouli; Mabel Owusu-Ankomah; Tijana Nikolich-Zugich; Aaron P Bloom; Juan Miguel Jimenez-Andrade; Tamara King; Frank Porreca; Mark A Nelson; Patrick W Mantyh; Todd W Vanderah
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.